Partners & Networks

For the benefit of its customers, Protagen AG cultivates strategic partnerships with companies and research institutes. Beyond an intensive know-how exchange, Protagen AG actively develops technologies that are ready for commercial applications.

Commercial Partners

• Biogenes GmbH, Berlin, Germany
• Oridis-Biomed GmbH, Graz, Austria
• Serva Electrophoresis GmbH, Heidelberg, Germany
• Mikrogen GmbH, Neuried, Germany
• Zelle Biotechnology, Mumbai, India
• TS DYNE Co., Ltd., Seoul, South Korea 

Research Networks

• University of Innsbruck, Austria, Urology Clinic (Univ Prof. Helmut Klocker)
• University of Duisburg-Essen, Germany, Neurological Clinic (Prof.. G. Wiltfang )
• Johns Hopkins Medical School, Dep. Of Urology (Prof. Alan Partin)
• Accelerated Cure Project for Multiple Sclerosis (Hollie Schmidt, VP of Scientific Operations)
• VU University Medical Center, Neurological Laboratory Clinical Chemistry and Multiple Sclerosis Center Amsterdam (Dr. Charlotte Teunissen)
• Technical University Munich, Klinikum rechts der Isar, Polyclinic (Univ. Prof. Dr. Bernhard Hemmer)
• University of Innsbruck, Austria, Dep.of Gynocology (Univ. Prof. Dr. Günter Daxenbichler)
• European Tumor Sample Institute (ETSI-med) GmbH, Hennigsdorf, Germany
• Blutspendedienst des Bayrischen Roten Kreuzes GmbH, München, Germany
• University of Mainz, Germany, Dermatology Clinic (Prof. Dr. Helmut Jonuleit)
• University of Mainz, Germany, Institute for Immunology (Prof. Dr. Edgar Schmitt)
• University for Applied Sciences, Gelsenkirchen, Germany (Prof. Dr. Heinrich Brinck)
• University of Bochum, Germany, Medical Proteome Center (Prof. Helmut E. Meyer)
• University of Applied Sciences, Bonn-Rhein-Sieg St. Augustin, Germany (Prof. Dr. Ralf Thiele)
• University of Bochum, Germany, Neurological Clinic (Prof. Gold, Dr. Andrew Chan)
• Clinique Lüdenscheid, Germany, Neurological Department (Dr. S. Schimrigk)
• University of Düsseldorf, Germany, Rheumatology Clinic (Prof. M. Schneider)

Protagen is actively involved in the following academic projects:

• cNEUPRO (Clinical Neuroproteomics of Neurodegenerative Diseases)
• EUCAAD (EU Consortium for Anticancer Antibody Development)
• LipidomicNet - EU Framework VII project
• CLIB2021 - Cluster for Industrial biotechnology
• Oncotyrol - Medical University Innsbruck, Consortium for Personalized Medicine